CFLAR and prostate carcinoma: Activated c-Fos/AP-1 primes PC-3 and LNCaP prostate cancer (PCa) cells to undergo apoptosis by directly binding the promoter region of the anti-apoptotic gene c-FLIP(L), thereby repressing its transcription [18].